Sight Sciences, Inc. Common Stock
$8.02
-$0.12 (-1.47%)
$7.97Day Range$8.32
Key Statistics
Market Cap
$448.42M
Shares Outstanding
55.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 15, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$8.32
Day High
$8.32
Day Low
$7.97
Volume
94.3K
VWAP
$8.04
Prev Close
$8.14
Transactions
--
Acc. Volume
--
About Sight Sciences, Inc. Common Stock
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841186 employees4040 CAMPBELL AVE,, MENLO PARK, CA, 94025(415) 889-0550IPO Jul 15, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001531177
- Composite FIGI
- BBG006BZHZC7
- Share Class FIGI
- BBG006BZHZD6
- Ticker Root
- SGHT
- SIC Code
- 3841
About Sight Sciences, Inc. Common Stock (SGHT) Stock
Sight Sciences, Inc. Common Stock (SGHT) closed the 2026-09-17 session at $8.02, down 1.47% versus the previous close (-0.12). The stock opened at $8.32 and traded between $7.97 and $8.32 during that session. Session trading volume was 94K shares. The volume-weighted average price (VWAP) is $8.04.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Sight Sciences, Inc. Common Stock has a market capitalization of $448.4 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. SGHT is listed on the XNAS exchange. The company employs approximately 186 people. Sight Sciences, Inc. Common Stock is headquartered in MENLO PARK, CA. The recorded listing date is 2021-07-15.
On this page you can find market SGHT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.